Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Mbx-8025 Lysine
2. Seladelpar Lysine Dihydrate
3. Mbx-8025 Lysine Dihydrate
4. 928821-40-3
5. Seladelpar Lysine [usan]
6. Mbx-8025 Lysine Salt, Dihydrate
7. N1429130kr
8. Seladelpar (lysine Dihydrate)
9. Unii-n1429130kr
10. Seladelpar Lysine (usan)
11. Chembl3989960
12. Wtkswpygzdcunq-jzxfcxspsa-n
13. Hy-19522c
14. Akos040747473
15. Cs-1068545
16. D11257
17. Q27284370
18. (2s)-2,6-diaminohexanoic Acid;2-[4-[(2r)-2-ethoxy-3-[4-(trifluoromethyl)phenoxy]propyl]sulfanyl-2-methylphenoxy]acetic Acid;dihydrate
19. (r)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenoxy)acetic Acid Compound With (s)-2,6-diaminohexanoic Acid Dihydrate
20. L-lysine (4-(((2r)-2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)sulfanyl)-2-methylphenoxy)acetate Dihydrate
21. L-lysine, 2-(4-(((2r)-2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenoxy)acetate, Hydrate (1:1:2)
1. 851528-79-5
2. Mbx-8025
3. Mbx-8025 (seladelpar)
4. Seladelpar
| Molecular Weight | 626.7 g/mol |
|---|---|
| Molecular Formula | C27H41F3N2O9S |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 15 |
| Rotatable Bond Count | 16 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 182 |
| Heavy Atom Count | 42 |
| Formal Charge | 0 |
| Complexity | 617 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 4 |
About the Company : HRV Pharma is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
About the Company : Maithri Drugs Pvt. Ltd. is a trusted global partner in Active Pharmaceutical Ingredients (APIs), supplying to pharmaceutical leaders in 60+ countries. With APIs spanning antivirals...
About the Company : Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.is a high-tech enterprise, which is an integration of R & D, producing and custom synthesis. The products quality is assured ...

About the Company : Viyash, true to its name, literally represents honesty and leadership in every sense. We are an integrated pharmaceutical company with a strong portfolio of niche formulations, ...

About the Company : Zydus is headquartered in Ahmedabad, India, and ranks 4th in the Indian pharmaceutical industry. The group has manufacturing sites and research facilities spread across five states...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code :
Brand Name : LIVDELZI
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 10MG BASE
Approval Date : 2024-08-14
Application Number : 217899
RX/OTC/DISCN : RX
RLD : Yes
TE Code :

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
07 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250506771103/en/Gileads-Livdelzi-Seladelpar-Demonstrated-Consistent-Efficacy-and-Safety-Regardless-of-Prior-Treatment-History-in-New-Data-Presented-at-EASL-2025

17 Apr 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/ipsens-liver-disease-drug-iqirvo-promising-launch-battle-gileads-livdelzi

20 Feb 2025
// BUSINESSWIRE

13 Dec 2024
// BUSINESSWIRE

15 Nov 2024
// BUSINESSWIRE

16 Aug 2024
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/fda-approval-livdelzi-gilead-launches-inflammatory-drug-first-time
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
69
PharmaCompass offers a list of Seladelpar Lysine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Seladelpar Lysine manufacturer or Seladelpar Lysine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Seladelpar Lysine manufacturer or Seladelpar Lysine supplier.
PharmaCompass also assists you with knowing the Seladelpar Lysine API Price utilized in the formulation of products. Seladelpar Lysine API Price is not always fixed or binding as the Seladelpar Lysine Price is obtained through a variety of data sources. The Seladelpar Lysine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Seladelpar manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Seladelpar, including repackagers and relabelers. The FDA regulates Seladelpar manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Seladelpar API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Seladelpar manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Seladelpar supplier is an individual or a company that provides Seladelpar active pharmaceutical ingredient (API) or Seladelpar finished formulations upon request. The Seladelpar suppliers may include Seladelpar API manufacturers, exporters, distributors and traders.
click here to find a list of Seladelpar suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Seladelpar as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Seladelpar API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Seladelpar as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Seladelpar and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Seladelpar NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Seladelpar suppliers with NDC on PharmaCompass.
Seladelpar Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Seladelpar GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Seladelpar GMP manufacturer or Seladelpar GMP API supplier for your needs.
A Seladelpar CoA (Certificate of Analysis) is a formal document that attests to Seladelpar's compliance with Seladelpar specifications and serves as a tool for batch-level quality control.
Seladelpar CoA mostly includes findings from lab analyses of a specific batch. For each Seladelpar CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Seladelpar may be tested according to a variety of international standards, such as European Pharmacopoeia (Seladelpar EP), Seladelpar JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Seladelpar USP).